The Call for Tender will be open until 13 November 2020. The Pre-commercial Public will be carried out for a value of up to € 4,620,000.

 

ICT-enabled monitoring to improve health status and optimise hypertension care

 

Needs:
The procurement aims to trigger new solutions to be developed and tested to address the challenge of the rising incidence of hypertension and the need for more effective management by empowering patients and the healthcare professionals involved in their care.

The procurement should address the procurers’ unmet needs relating to different aspects (building blocks) of hypertension care:

– early detection and prevention

– healthier lifestyle and nutrition

– optimised drug therapy and improving treatment adherence

– use of devices and remote monitoring

– personalised decision support

– interoperability and integration

– quality and outcome reporting

– patient-professional collaboration and co-ordination

– training and education.

 

GO TO CALL DETAILS

 

Looking for partners?

If you want to apply with other partners to meet all the requirements of the tender, check the web section where you can see the companies that have already registered.

We also invite you to register to be part of the Matchmaking and give visibility to your participation. To register you will first need to fill in the Open Market Consultation Questionnaire.

 

CHECK REGISTERED COMPANIES   |   YES, I ALSO WANT TO REGISTER ON THE MATCHMAKING

 

Any question?

Send an email to suppliers@hsmonitor-pcp.eu or contact us through the web form. The answers will be regularly published in a section dedicated to the frequently asked questions (FAQS) on the official website.

 

More about the project

HSMonitor is a pre-commercial procurement (PCP) project investing in Research and Development (R&D) services towards innovative ICT-enabled monitoring solutions to improve health status and optimise hypertension care.

Five healthcare providers from four countries are engaged in the procurement, catering to a combined population of over 96 million people, of which over 31 million have hypertension.

Ticbiomed is the partner leading the Open Market Consultation (OMC)